CIK 0002022626 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Upstream Bio, Inc.
Sign in to watch- Ticker
- UPB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-208-2466
- Business address
- 890 WINTER STREET, SUITE 200, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $27,604
- in 5 filings
Net −$27,604. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-15 | ORBIMED ADVISORS LLC Director | Conversion · Series A redeemable convertible preferred stock | −524,500 | 0 | ||
| 2024-10-15 | ORBIMED ADVISORS LLC Director | Conversion · Series A redeemable convertible preferred stock | −2,098,000 | 0 | ||
| 2024-10-15 | ORBIMED ADVISORS LLC Director | Conversion · Series B redeemable convertible preferred stock | −197,456 | 0 | ||
| 2024-10-15 | ORBIMED ADVISORS LLC Director | Conversion · Series B redeemable convertible preferred stock | −789,833 | 0 | ||
| 2024-10-15 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | Conversion | +894,733 | 894,733 | ||
| 2024-10-15 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | Conversion · Series B redeemable convertible preferred stock | −852,940 | 0 | ||
| 2024-10-10 | Renaud Ronald C JR Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 | ||
| 2024-10-10 | Beckman Daniella Director | Grant or award · Stock Option (Right to Buy) | +34,681 | 34,681 | ||
| 2024-10-10 | Chimovits Erez Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 | ||
| 2024-10-10 | Ruddy Marcella K. Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 | ||
| 2024-10-10 | Fleming Harold Edward Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 | ||
| 2024-10-10 | Ratcliffe Liam Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 |
Page 4 of 4 · 72 trades